학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 579건 | 목록 1~20
Academic Journal
Falcó-Roget A; Infectious Diseases Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Medicine Department, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Vall Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Albasanz-Puig A; Infectious Diseases Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Medicine Department, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Vall Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Pérez-González A; Hematology Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Serradell S; Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Guillén A; Medicine Department, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Internal Medicine Department, Unit of Systemic Autoimmune Diseases, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Díaz-Lagares C; Medicine Department, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Vall Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Intensive Care Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Revilla E; Pneumology Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Los-Arcos I; Infectious Diseases Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Len Ò; Infectious Diseases Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Medicine Department, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Ruiz-Camps I; Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Martín-Gómez MT; Medicine Department, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Microbiology Department, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE
Academic Journal
Cuenca Fito E; Servicio Medicina Intensiva, Complexo Hospitalario Universitario de Ourense, Ourense, Spain. Electronic address: ecuencafito@gmail.com.; Mayor-Vázquez E; Área Vigilancia Intensiva, Hospital Clínic, Barcelona, Spain.; Díaz Lagares C; Servicio Medicina Intensiva, Hospital Universitario Vall d'Hebron, Barcelona, Spain.; Vidal Tegedor B; Servicio Medicina Intensiva, Hospital General Universitario de Castellón, Castellón, Spain.; Lázaro Martín NI; Servicio Medicina Intensiva, Hospital Universitario de Burgos, Burgos, Spain.; López Fernández A; Servicio Medicina Intensiva, Hospital Universitario La Paz, Madrid, Spain.; Sanchez Montori L; Servicio Medicina Intensiva, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.; Isern Í; Servicio Medicina Intensiva, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.; Cabanillas Carrillo A; Servicio Medicina Intensiva, Hospital Universitario del Sureste, Madrid, Spain.; Sánchez Gómez J; Servicio Medicina Intensiva, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.; Gómez Grande ML; Servicio Medicina Intensiva, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.; Fernández Rodríguez A; Servicio Medicina Intensiva, Hospital Universitario Lucus Augusti, Lugo, Spain.; Espejo A; Servicio Medicina Intensiva, Hospital Universitario de Alava, Vitoria-Gasteiz, Araba, Spain.; Díaz Díaz D; Servicio Medicina Intensiva, Hospital Universitario Infanta Leonor, Madrid, Spain.; García Roche A; Servicio Medicina Intensiva, Hospital Universitario Vall d'Hebron, Barcelona, Spain.; Márquez M; Servicio Medicina Intensiva, Hospital General Universitario de Toledo, Toledo, Spain.; Molina Cortés M; Servicio Medicina Intensiva, Hospital General Universitario de Jaén, Jaén, Spain.; Valero N; Servicio Medicina Intensiva, Hospital Universitario de Getafe, Madrid, Spain.; Gracia Romero M; Servicio Medicina Intensiva, Hospital Universitario de Jerez, Jerez de la Frontera, Cádiz, Spain.; Eiras Abalde F; Servicio de Medicina Intensiva, Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS; Grupo de Investigación CIES-CRITIC, Instituto de Investigación Sanitaria Galicia Sur (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Pontevedra, Spain.; Higuera Lucas J; Servicio Medicina Intensiva, Hospital Universitario de Cruces, Barakaldo, Bizkaia, Spain.; Albalá Martínez N; Servicio Medicina Intensiva, Hospital Clínico Universitario de Salamanca, Salamanca, Spain.; Jiménez Quintana MDM; Servicio Medicina Intensiva, Hospital Universitario Virgen de las Nieves, Granada, Spain.; Orejas Gallego A; Servicio Medicina Intensiva, Hospital Universitario Severo Ochoa, Madrid, Spain.; de la Casa RM; Servicio Medicina Intensiva, Hospital Universitario HLA Moncloa, Madrid, Spain.; Monge Donaire D; Servicio Medicina Intensiva, Hospital Virgen de la Concha, Zamora, Spain.; Lesmes González de Aledo A; Servicio Medicina Intensiva, Hospital Universitario 12 de Octubre, Madrid, Spain.; Bellès Casas A; Servicio Medicina Intensiva, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Larrañaga Sigwald L; Servicio Medicina Intensiva, Complexo Hospitalario Universitario de Ourense, Ourense, Spain.; Portillo Sánchez S; Servicio Medicina Intensiva, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; Bardal Ruiz A; Servicio Medicina Intensiva, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid, Spain.; Lipperheide I; Servicio Medicina Intensiva, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, Spain.; Luján Varas J; Servicio Medicina Intensiva, Hospital Príncipe de Asturias, Madrid, Spain.; Recena Pérez P; Servicio Medicina Intensiva, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain.; Gómez-Acebo I; Grupo de Medicina Preventiva, University of Cantabria, Santander, Spain; Instituto de Investigación Sanitaria IDIVAL-Valdecilla, Santander, Spain; Consorcio de Investigación Biomédica en Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Publisher: Elsevier España Country of Publication: Spain NLM ID: 101717568 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2173-5727 (Electronic) Linking ISSN: 21735727 NLM ISO Abbreviation: Med Intensiva (Engl Ed) Subsets: MEDLINE
Academic Journal
Mayor-Vázquez E; Hospital Clínic Barcelona (HCB), Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain; Grupo de Trabajo en Hemostasia, Hematología y Oncología Crítica (GTHHOC), Sociedad Española de Medicina Intensiva y Unidades Coronarias (SEMICYUC), Spain.; Cuenca Fito E; Complexo Hospitalario Universitario de Ourense (CHUO), Ourense, Spain; Grupo de Trabajo en Hemostasia, Hematología y Oncología Crítica (GTHHOC), Sociedad Española de Medicina Intensiva y Unidades Coronarias (SEMICYUC), Spain. Electronic address: ecuencafito@gmail.com.; Marcos-Neira P; Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain; Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain; Grupo de Trabajo en Hemostasia, Hematología y Oncología Crítica (GTHHOC), Sociedad Española de Medicina Intensiva y Unidades Coronarias (SEMICYUC), Spain.; Díaz-Lagares C; Hospital Vall d'Hebron, Barcelona, Spain; Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain; Grupo de Trabajo en Hemostasia, Hematología y Oncología Crítica (GTHHOC), Sociedad Española de Medicina Intensiva y Unidades Coronarias (SEMICYUC), Spain.; Gomila-Sintes C; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Grupo de Trabajo en Hemostasia, Hematología y Oncología Crítica (GTHHOC), Sociedad Española de Medicina Intensiva y Unidades Coronarias (SEMICYUC), Spain.; Albalá N; Complejo Asistencial Universitario de Salamanca, Salamanca, Spain; Grupo de Trabajo en Hemostasia, Hematología y Oncología Crítica (GTHHOC), Sociedad Española de Medicina Intensiva y Unidades Coronarias (SEMICYUC), Spain.; García-Roche A; Hospital Vall d'Hebron, Barcelona, Spain; Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain; Grupo de Trabajo en Hemostasia, Hematología y Oncología Crítica (GTHHOC), Sociedad Española de Medicina Intensiva y Unidades Coronarias (SEMICYUC), Spain.; Castro P; Hospital Clínic Barcelona (HCB), Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain; Institut d'investigacions biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Grupo de Trabajo en Hemostasia, Hematología y Oncología Crítica (GTHHOC), Sociedad Española de Medicina Intensiva y Unidades Coronarias (SEMICYUC), Spain.
Publisher: Elsevier España Country of Publication: Spain NLM ID: 101717568 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2173-5727 (Electronic) Linking ISSN: 21735727 NLM ISO Abbreviation: Med Intensiva (Engl Ed) Subsets: MEDLINE
Academic Journal
Lescuyer G; Laboratoire de Biologie Médicale Multi-Sites, Department of Biochemistry and Molecular Biology, University of Lyon 1, Institute of Pharmaceutical and Biological Sciences, Center for Innovation in Cancerology of Lyon EA 3738, Lyon-Sud Hospital, Hospices Civils de Lyon, Pierre-Bénite, France.; Harlé A; Biopathology Department, Institut de Cancérologie de Lorraine-Alexis Vautrin, Centre National de la Recherche Scientifique UMR7039 Centre de Recherche en Automatique de Nancy Université de Lorraine, Vandœuvre-lès-Nancy, France.; Kumar HS; Neuberg Centre for Genomic Medicine, Ahmedabad, India.; Constantoulakis P; Genotypos-Science Labs, Athens, Greece.; Pfarr N; Institute of Pathology, School of Medicine and Health, Technical University Munich, Munich, Germany.; Heitzer E; Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.; Michon C; Institut de Cancérologie de l'Ouest, Laboratoire d'Oncopharmacologie et Pharmacogénétique, Angers, France.; Russo G; Department of Public Health, Università degli Studi di Napoli-Azienda Ospedaliera Universitaria Federico II, Naples, Italy.; Speel EM; Department of Pathology and Clinical Bioinformatics, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pathology, GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands.; Piecyk M; Laboratoire de Biologie Médicale Multi-Sites, Department of Biochemistry and Molecular Biology, University of Lyon 1, Institute of Pharmaceutical and Biological Sciences, Center for Innovation in Cancerology of Lyon EA 3738, Lyon-Sud Hospital, Hospices Civils de Lyon, Pierre-Bénite, France.; Husson M; Biopathology Department, Institut de Cancérologie de Lorraine-Alexis Vautrin, Centre National de la Recherche Scientifique UMR7039 Centre de Recherche en Automatique de Nancy Université de Lorraine, Vandœuvre-lès-Nancy, France.; Christopoulou G; Genotypos-Science Labs, Athens, Greece.; Mayr EM; Institute of Pathology, School of Medicine and Health, Technical University Munich, Munich, Germany.; Koppermann ML; Institute of Pathology, School of Medicine and Health, Technical University Munich, Munich, Germany.; Passot C; Institut de Cancérologie de l'Ouest, Laboratoire d'Oncopharmacologie et Pharmacogénétique, Angers, France.; Graf R; Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.; Aoul AH; Laboratoire d'Oncogénétique Moléculaire, Département de Biologie du Cancer, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.; Bourdon V; Laboratoire d'Oncogénétique Moléculaire, Département de Biologie du Cancer, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.; Dubbink HJ; Department of Pathology and Clinical Bioinformatics, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.; van Marion R; Department of Pathology and Clinical Bioinformatics, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.; Demers I; Department of Pathology, GROW-Research Institute for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands.; Dingemans AC; Department of Respiratory Medicine, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.; Troncone G; Department of Public Health, Università degli Studi di Napoli-Azienda Ospedaliera Universitaria Federico II, Naples, Italy.; Pepe F; Department of Public Health, Università degli Studi di Napoli-Azienda Ospedaliera Universitaria Federico II, Naples, Italy.; Muinelo-Romay L; Liquid Biopsy Analysis Unit, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago de Compostela, University Clinical Hospital of Santiago (CHUS/SERGAS), CIBERONC, Santiago de Compostela, Spain.; Díaz-Lagares Á; Epigenomics Unit, Cancer Epigenomics, Translational Medical Oncology Group, Health Research Institute of Santiago de Compostela, University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain; Centro de Investigación Biomédica en Red Cáncer, El Instituto de Salud Carlos III, Madrid, Spain; Department of Clinical Analysis, University Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain.; Rodriguez-Casanova A; Epigenomics Unit, Cancer Epigenomics, Translational Medical Oncology Group, Health Research Institute of Santiago de Compostela, University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain; Centro de Investigación Biomédica en Red Cáncer, El Instituto de Salud Carlos III, Madrid, Spain.; Lago Lestón RM; Liquid Biopsy Analysis Unit, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago de Compostela, University Clinical Hospital of Santiago (CHUS/SERGAS), CIBERONC, Santiago de Compostela, Spain.; Pathak D; Neuberg Centre for Genomic Medicine, Ahmedabad, India.; Shah P; Neuberg Centre for Genomic Medicine, Ahmedabad, India.; Parillaud RV; Hedera Dx, Epalinges, Switzerland.; Martínez de Ilarduya O; Hedera Dx, Epalinges, Switzerland.; Behr J; Hedera Dx, Epalinges, Switzerland.; Rapin A; Hedera Dx, Epalinges, Switzerland.; Vetterli T; Hedera Dx, Epalinges, Switzerland.; Boppudi SM; Hedera Dx, Epalinges, Switzerland.; Malapelle U; Department of Public Health, Università degli Studi di Napoli-Azienda Ospedaliera Universitaria Federico II, Naples, Italy.; Payen L; Laboratoire de Biologie Médicale Multi-Sites, Department of Biochemistry and Molecular Biology, University of Lyon 1, Institute of Pharmaceutical and Biological Sciences, Center for Innovation in Cancerology of Lyon EA 3738, Lyon-Sud Hospital, Hospices Civils de Lyon, Pierre-Bénite, France. Electronic address: lea.payen-gay@chu-lyon.fr.
Publisher: Elsevier Country of Publication: United States NLM ID: 100893612 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-7811 (Electronic) Linking ISSN: 15251578 NLM ISO Abbreviation: J Mol Diagn Subsets: MEDLINE
Academic Journal
Díaz-Lagares C; Intensive Care Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, SODIR Research Group, Vall d'Hebron Institut de Recerca (VHIR), Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain. Electronic address: candido.diaz@vallhebron.cat.; García-Roche A; Intensive Care Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, SODIR Research Group, Vall d'Hebron Institut de Recerca (VHIR), Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.; Pacheco A; Intensive Care Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, SODIR Research Group, Vall d'Hebron Institut de Recerca (VHIR), Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.; Ros J; Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, C/Natzaret, 115-117, 08035, Barcelona, Spain.; Plata-Menchaca EP; Intensive Care Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, SODIR Research Group, Vall d'Hebron Institut de Recerca (VHIR), Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.; Albasanz A; Infectious Diseases Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.; Pérez D; Intensive Care Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, SODIR Research Group, Vall d'Hebron Institut de Recerca (VHIR), Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.; Saoudi N; Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, C/Natzaret, 115-117, 08035, Barcelona, Spain.; Ruiz-Camps I; Infectious Diseases Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.; Élez E; Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, C/Natzaret, 115-117, 08035, Barcelona, Spain.; Ferrer R; Intensive Care Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, SODIR Research Group, Vall d'Hebron Institut de Recerca (VHIR), Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Publisher: Elsevier España Country of Publication: Spain NLM ID: 101717568 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2173-5727 (Electronic) Linking ISSN: 21735727 NLM ISO Abbreviation: Med Intensiva (Engl Ed) Subsets: MEDLINE
Academic Journal
Brozos-Vázquez E; Medical Oncology Department, University Hospital of A Coruña (CHUAC), A Coruña, Spain.; Toledano-Fonseca M; Cancer Network Biomedical Research Center (CIBERONC), Madrid, Spain; Maimónides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.; Costa-Fraga N; Epigenomics Unit, Cancer Epigenomics, Translational Medical Oncology Group (ONCOMET); Clinical University Hospital & Health Research Institute of Santiago de Compostela. CIBERONC; University of Santiago de Compostela, Santiago de Compostela, Spain.; García-Ortiz MV; Cancer Network Biomedical Research Center (CIBERONC), Madrid, Spain; Maimónides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.; Díaz-Lagares Á; Epigenomics Unit, Cancer Epigenomics, Translational Medical Oncology Group (ONCOMET); Clinical University Hospital & Health Research Institute of Santiago de Compostela. CIBERONC; Department of Clinical Analysis, University Hospital Complex of Santiago de Compostela (CHUS), Santiago de Compostela, Spain.; Rodríguez-Ariza A; Cancer Network Biomedical Research Center (CIBERONC), Madrid, Spain; Maimónides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain; Medical Oncology Department, Reina Sofía University Hospital, Córdoba, Spain. Electronic address: antonio.rodriguez.exts@juntadeandalucia.es.; Aranda E; Cancer Network Biomedical Research Center (CIBERONC), Madrid, Spain; Maimónides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain; Medical Oncology Department, Reina Sofía University Hospital, Córdoba, Spain; Department of Medicine, Faculty of Medicine, University of Córdoba, Córdoba, Spain.; López-López R; Clinical University Hospital & Health Research Institute of Santiago de Compostela. CIBERONC; Medical Oncology Department & Translational Medical Oncology Group-ONCOMET, Spain; Oncology at Santiago de Compostela School of Medicine, Spain.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Díaz-Lagares, A.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어